eFFECTOR Therapeutics, Inc. (EFTR)
OTCMKTS · Delayed Price · Currency is USD
0.0002
0.00 (0.00%)
At close: Nov 18, 2026
eFFECTOR Therapeutics Market Cap
eFFECTOR Therapeutics has a market cap or net worth of $941 as of November 18, 2026. It is the 52,543rd most valuable company in the world and the 8,440th biggest in the United States. Its market cap has decreased by 66.67% in one year.
Market Cap
941.00
Enterprise Value
n/a
Revenue
n/a
Global Rank
Country Rank
#8,440 United States
PE Ratio
n/a
ChartMarket Cap Chart
Since March 1, 2021, eFFECTOR Therapeutics's market cap has decreased from 218.96M to 941.00, a decrease of -100.00%. That is a compound annual growth rate of -88.47%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 18, 2026 | 941.00 | - |
| Dec 31, 2025 | 941.00 | - |
| Dec 31, 2024 | 941.00 | -100.00% |
| Dec 29, 2023 | 30.20M | 68.61% |
| Dec 30, 2022 | 17.91M | -94.64% |
| Dec 31, 2021 | 334.28M | 52.66% |
| Mar 1, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| DNAPrint Genomics | 1.30K |
| GlobeStar Therapeutics | 1.24K |
| ObsEva | 1.17K |
| Adhera Therapeutics | 1.16K |
| Alzex Neuropharma | 1.05K |
| Panbela Therapeutics | 971.00 |
| American Oriental Bioengineering | 949.00 |
| ZyVersa Therapeutics | 810.00 |